These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Patients with and without prior urolithiasis have hypocitraturia and incident kidney stones while on topiramate. Kaplon DM; Penniston KL; Nakada SY Urology; 2011 Feb; 77(2):295-8. PubMed ID: 20888032 [TBL] [Abstract][Full Text] [Related]
4. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment. Caudarella R; Vescini F Arch Ital Urol Androl; 2009 Sep; 81(3):182-7. PubMed ID: 19911682 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and spot urine risk factors for renal stones in children taking topiramate. Corbin Bush N; Twombley K; Ahn J; Oliveira C; Arnold S; Maalouf NM; Sakhaee K J Pediatr Urol; 2013 Dec; 9(6 Pt A):884-9. PubMed ID: 23375465 [TBL] [Abstract][Full Text] [Related]
6. Induction of progressive profound hypocitraturia with increasing doses of topiramate. Warner BW; LaGrange CA; Tucker T; Bensalem-Owen M; Pais VM Urology; 2008 Jul; 72(1):29-32; discussion 32-3. PubMed ID: 18436283 [TBL] [Abstract][Full Text] [Related]
7. [Citrate and renal stones]. del Valle EE; Spivacow FR; Negri AL Medicina (B Aires); 2013; 73(4):363-8. PubMed ID: 23924538 [TBL] [Abstract][Full Text] [Related]
8. Topiramate increases biochemical risk of nephrolithiasis. Lamb EJ; Stevens PE; Nashef L Ann Clin Biochem; 2004 Mar; 41(Pt 2):166-9. PubMed ID: 15025812 [TBL] [Abstract][Full Text] [Related]
10. The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers. Pinheiro VB; Baxmann AC; Tiselius HG; Heilberg IP Urology; 2013 Jul; 82(1):33-7. PubMed ID: 23602798 [TBL] [Abstract][Full Text] [Related]
11. Biochemical and stone-risk profiles with topiramate treatment. Welch BJ; Graybeal D; Moe OW; Maalouf NM; Sakhaee K Am J Kidney Dis; 2006 Oct; 48(4):555-63. PubMed ID: 16997051 [TBL] [Abstract][Full Text] [Related]
12. Alkali absorption and citrate excretion in calcium nephrolithiasis. Sakhaee K; Williams RH; Oh MS; Padalino P; Adams-Huet B; Whitson P; Pak CY J Bone Miner Res; 1993 Jul; 8(7):789-94. PubMed ID: 8352061 [TBL] [Abstract][Full Text] [Related]
13. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation. Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919 [TBL] [Abstract][Full Text] [Related]
14. Dietary management of hypocitraturia in children with urolithiasis: results from a systematic review. Castellani D; Giulioni C; De Stefano V; Brocca C; Fuligni D; Galosi AB; Teoh JY; Sarica K; Gauhar V World J Urol; 2023 May; 41(5):1243-1250. PubMed ID: 36645461 [TBL] [Abstract][Full Text] [Related]
15. Treatment Response in Patients with Stones, and Low Urinary pH and Hypocitraturia Stratified by Body Mass Index. Astroza GM; Neisius A; Tsivian M; Preminger GM; Lipkin ME J Urol; 2016 Mar; 195(3):653-7. PubMed ID: 26393903 [TBL] [Abstract][Full Text] [Related]
16. Urinary citrate in kidney stone disease. Usui Y; Matsuzaki S; Matsushita K; Shima M Tokai J Exp Clin Med; 2003 Jul; 28(2):65-70. PubMed ID: 14714831 [TBL] [Abstract][Full Text] [Related]
17. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group. Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F; Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027 [TBL] [Abstract][Full Text] [Related]